Table 1 AZD4785 detection in plasma-derived EVs.

From: Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and extracellular vesicle recycling

Treatment regime

Plasma collection time after the last dose

72 h

168 h

Plasma nM

EVs (fMol/106)

EVs plasma, nM

Plasma nM

EVs (fMol/106)

EVs plasma, nM

PBS

Not detected

NA

NA

Not detected

NA

NA

AZD4785 125 mpk/wk

12.48

0.07

0.85

4.28

0.03

0.11

AZD4785 250 mpk/wk

18.72

0.07

0.80

6.57

0.02

0.10